Abilify Effects
Links shared publicly online about this topic
Treat Schizophrenia and Bipolar Disorder With Abilify
health.ezinemark.com — “Typically Abilify is a medication that you can avail of only with a doctor's prescription to treat diseases like schizophrenia and bipolar disorder and in recent years it has also been found effective to treat the irritation that arises in autistic patients. It is also used in the treatment of major depression in combination w8ith an antidepressant medication and this is termed augmentation.” View full resource at health.ezinemark.com
Most Recently Shared on September 21, 2010 at 1:59 pm By:
Peter H Brown Doctor and Psychologist
Treat Schizophrenia and Bipolar Disorder With Abilify http://bit.ly/dD3SW5 #bipolar
Abilify | Aripiprazole | Bipolar Disorder | Maintenance | Bipolar Beat
blogs.psychcentral.com — “Articles have touted the effectiveness of Abilify (aripiprazole) as a maintenance treatment for bipolar disorder, but no reliable studies support this claim.” View full resource at blogs.psychcentral.com
Most Recently Shared on May 6, 2011 at 8:30 pm By:
Bipolar Beat: Evidence for Abilify (Aripiprazole) in Maintenance of Bipolar Disorder Questioned http://bit.ly/l7Gt7J
Just Say No To Abilify - YouTube
youtube.com — “What really are the side effects of Abilify as stated in the commercials? Here they are.” View full resource at youtube.com
Most Recently Shared on September 2, 2011 at 4:59 am By:
Jack Friday - PharmaGossip Health Blog
RT @Meriditht: Cute Video: "Just Say No to Abilify" http://t.co/J7AAAs1
The Carlat Psychiatry Blog: Abilify, the Journal of Clinical Psychiatry, and "Akathisia-gate"
carlatpsychiatry.blogspot.com — “Supporting the search for honesty in medical education” View full resource at carlatpsychiatry.blogspot.com
Most Recently Shared on May 11, 2009 at 1:27 pm By:
Michael Lara, MD Physician, Doctor, and Psychiatrist
"Abilify and 'Akathisia-Gate" The Story of How Side Effects Were Minimized by Bristol-Meyers. http://bit.ly/180rwz
The latest medication to treat schizophrenia "ABILIFY" launched in Canada
news-medical.net — “A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.” View full resource at news-medical.net
Most Recently Shared on October 6, 2009 at 7:11 pm By:
HIV/AIDS News: The latest medication to treat schizophrenia "ABILIFY" launched in Canada: A new t.. http://bit.ly/189U0t
Bipolar-disorder Related Drugs, Abilify, Quetiapine - Drugs - EverydayHealth.com
everydayhealth.com — “Find information on prescription and OTC drugs that treat Bipolar-disorder like Abilify, Abilify Discmelt, Aripiprazole, Calan, Calan SR, Carbamazepine, Carbatrol, Catapres, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3. Find medical information on side effects, drug interactions, dosage, and user ratings and reviews.” View full resource at everydayhealth.com
Most Recently Shared on April 8, 2010 at 3:09 am By:
Peter H Brown Doctor and Psychologist
Bipolar-disorder Related Drugs, Abilify, Quetiapine ... http://bit.ly/b62GaM #bipolar
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
drugs.com — “Abilify (aripiprazole) is used to treat schizophrenia, Bipolar I Disorder, depression and irritability associated with autistic disorder. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 21, 2011 at 10:15 pm By:
Drugs and Devices OW OW Health
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug
News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health
reuters.com — “News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health” View full resource at reuters.com
Most Recently Shared on September 10, 2010 at 3:45 am By:
Hisham Rana, MD Doctor and Physician
News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health
U.S. Food and Drug Administration Approves Abilify (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
drugs.com — “Abilify (aripiprazole) is used to treat irritability associated with autistic disorder in pediatric patients. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 24, 2009 at 12:10 am By:
FDA Approves Abilify for Irritability Associated with Autistic Disorder in Pediatric Patients - http://bit.ly/62jJ8P
FDA panel recommends change to label of Abilify - Related Stories - AAP SmartBrief
smartbrief.com — “An FDA panel unanimously concluded that the label of Bristol-Myers Squibb's antipsychotic Abilify for use in children lacks information on the risk of excessive weight gain. The panel advised Bristol-Myers to keep monitoring pediatric use of the drug and move data on its metabolic effect on children” View full resource at smartbrief.com
Most Recently Shared on December 11, 2009 at 6:07 am By:
Clara Song Pediatrician, Physician, and Doctor
FDA panel recommends change to label of Abilify http://sbne.ws/r/3qaF
Experts question long-term efficacy of Abilify for bipolar disorder - Related Stories - AANP SmartBrief
smartbrief.com — “Researchers cited a lack of evidence for the effectiveness of Otsuka Pharmaceutical and Bristol-Myers Squibb's Abilify as maintenance therapy for bipolar disorder. Only one randomized, double-blind clinical trial evaluated Abilify's long-term benefits, and that study had limitations, researchers no--” View full resource at smartbrief.com
Most Recently Shared on May 4, 2011 at 3:33 pm By:
UK's NICE wants more data on BMS schizophrenia drug
health.yahoo.net — “Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.” View full resource at health.yahoo.net
Most Recently Shared on September 10, 2010 at 1:40 am By:
UK's NICE wants more data on BMS schizophrenia drug http://bit.ly/9QGCG1
NICE Requests More Data On Aripiprazole For Schizophrenia
medicalnewstoday.com — “In draft guidance , published today (10 September 2010), NICE has asked Bristol-Myers” View full resource at medicalnewstoday.com
Most Recently Shared on September 10, 2010 at 6:00 pm By:
NICE Requests More Data On Aripiprazole For Schizophrenia http://mnt.to/3JBh #schizophrenia
UK's NICE wants more data on schizophrenia drug - QualityPoint Technologies
qualitypointtech.net — “LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness. (Source: Reuters: Health)” View full resource at qualitypointtech.net
Most Recently Shared on September 10, 2010 at 4:36 pm By:
UK's NICE wants more data on schizophrenia drug: LONDON (Reuters) - Britain's healthcare cost watchdog said it w... http://bit.ly/d8QfPH
NICE Requests More Data On Aripiprazole For Schizophrenia - QualityPoint Technologies
qualitypointtech.net — “In draft guidance , published today (10 September 2010), NICE has asked Bristol-Myers Squibb and Otsuka Pharmaceuticals to provide more data on the effectiveness of their product, aripiprazole (Abilify), as a treatment for schizophrenia in people aged 15 to 17 years. This draft guidance has been issued for consultation and the manufacturer now has an opportunity to respond to the independent Appraisal Committee's considerations and requests...” View full resource at qualitypointtech.net
Most Recently Shared on September 11, 2010 at 5:12 am By:
NICE Requests More Data On Aripiprazole For Schizophrenia: In draft guidance , published today (10 September 2010)... http://bit.ly/cp0fpF
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
-
Psych Central
Psychology and mental health information and support, since 1995. Pages are maintained by Brandi-Ann Uyemura, Associate Editor.
-
Jack Friday - PharmaGossip
A Big Pharma Insider. Any post may be a joke!
Advertisement
